| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: a nested case–control study
|
Kronzer, Vanessa L
|
|
|
5 |
2 |
p. e77-e87
|
artikel
|
| 2 |
Brain mapping inflammatory-arthritis-related fatigue in the pursuit of novel therapeutics
|
Stefanov, Kristian
|
|
|
5 |
2 |
p. e99-e109
|
artikel
|
| 3 |
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study
|
Md Yusof, Md Yuzaiful
|
|
|
5 |
2 |
p. e88-e98
|
artikel
|
| 4 |
Clinical medical education under circumstances of war
|
Novick, Adrienne Feller
|
|
|
5 |
2 |
p. e65
|
artikel
|
| 5 |
Clinical trial design: time to accelerate the pace of change?
|
The Lancet Rheumatology,
|
|
|
5 |
2 |
p. e59
|
artikel
|
| 6 |
Navigating use of rituximab during the COVID-19 pandemic
|
Elahee, Mehreen
|
|
|
5 |
2 |
p. e63-e64
|
artikel
|
| 7 |
Predicting rheumatoid arthritis-associated interstitial lung disease: filling the void
|
Hutchinson, David
|
|
|
5 |
2 |
p. e61-e63
|
artikel
|
| 8 |
Preventing myofibre necrosis in immune-mediated necrotising myopathy—is complement inhibition effective?
|
Limaye, Vidya Sadanand
|
|
|
5 |
2 |
p. e60-e61
|
artikel
|
| 9 |
Pseudoxanthomatous rheumatoid nodule
|
Horino, Taro
|
|
|
5 |
2 |
p. e110
|
artikel
|
| 10 |
Research in Brief
|
Thorley, Jennifer
|
|
|
5 |
2 |
p. e66
|
artikel
|
| 11 |
Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
|
Mammen, Andrew L
|
|
|
5 |
2 |
p. e67-e76
|
artikel
|
Tijdschrift beschrijving